Quick Answer
BIO-RAD LABORATORIES, INC. reported R&D Expense of $275.60 million for fiscal year 2025.
BIO-RAD LABORATORIES, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $275.60M | -6.9% |
| 2024 | $295.90M | +19.6% |
| 2023 | $247.40M | -3.7% |
| 2022 | $256.90M | -1.4% |
| 2021 | $260.64M | +19.7% |
| 2020 | $217.76M | +7.4% |
| 2019 | $202.71M | +1.8% |
| 2018 | $199.20M | -20.4% |
| 2017 | $250.16M | +21.6% |
| 2016 | $205.71M | +6.6% |
| 2015 | $192.97M | -12.4% |
| 2014 | $220.33M | +4.4% |
| 2013 | $210.95M | +0.8% |
| 2012 | $209.20M | +17.8% |
| 2011 | $177.60M | +3.1% |
| 2010 | $172.27M | +5.3% |
| 2009 | $163.59M | +2.5% |
| 2008 | $159.52M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $71.30M | -21.6% | +17.9% |
| June 30, 2025 | $60.50M | +2.7% | -17.7% |
| March 31, 2025 | $73.50M | +10.7% | -19.2% |
| September 30, 2024 | $91.00M | +109.0% | +54.5% |
| June 30, 2024 | $58.90M | -9.4% | -11.3% |
| March 31, 2024 | $66.40M | -11.4% | +52.5% |
| September 30, 2023 | $43.53M | -34.8% | -33.1% |
| June 30, 2023 | $65.04M | +1.1% | -13.2% |
- BIO-RAD LABORATORIES, INC. showed a decrease of -6.9% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2025 period, BIO-RAD LABORATORIES, INC.’s r&d expense has grown by 72.8% (from $159.52 million to $275.60 million).
- The most recent figure is from BIO-RAD LABORATORIES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: